Why Profound Medical Corp.’s (PROF) Stock Is Down 5.10%
As of Tuesday, October 13, Profound Medical Corp.’s PROF share price has dipped by 5.10%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Stock Evaluator: Profound Medical Corp. (PROF)
Profound Medical Corp. PROF
$6.31
-0.31
-4.68%
October 15, 2026 4:00:00 PM
EST
Volume: 174,899
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company’s lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
Commentary & Analysis
Why Profound Medical Corp.’s (PROF) Stock Is Up 11.09%
As of Thursday, October 08, Profound Medical Corp.’s PROF share price has surged by 11.09%, which has investors questioning if this is right time to sell.Michael Rose
Why Profound Medical Corp.’s (PROF) Stock Is Up 17.08%
As of Thursday, October 08, Profound Medical Corp.’s PROF share price has surged by 17.08%, which has investors questioning if this is right time to sell.Tudor Pop
Why Profound Medical Corp.’s (PROF) Stock Is Up 5.05%
As of Monday, October 05, Profound Medical Corp.’s PROF share price has surged by 5.05%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Profound Medical Corp.’s (PROF) Stock Is Up 5.03%
As of Monday, September 21, Profound Medical Corp.’s PROF share price has surged by 5.03%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | PROF | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $241.8 | $376.8 | 30% |
|
| Shares Out (Mil) | 36.4 | 40.7 | 41% |
|
| Institutional Ownership | 94.7% | 83.2% | 65% |
|
| Float (Mil) | 35.5 | 35.1 | 39% |
|
| Beta | 0.53 | 0.85 | 30% |
|
| Avg Daily Volume (000s) | 526 | 314 | 59% |
|
| Price Change (52-week) |
10.7% | 61.6% | 62% |
|
| Growth | PROF | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 17.1% | 11.8% | 77% |
|
| Net Income (5yr) | (14.5%) | (5.5%) | 26% |
|
| EPS (5yr) | (2.4%) | 10.4% | 28 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (47.5%) | (15.5%) | 8% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 4 | 5 | |
| Current EPS | ($0.195) | ($0.838) | ($0.588) | |
| Month Ago EPS | ($0.222) | ($0.840) | ($0.573) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | ($0.235) | ($0.817) | ($0.727) | |
| Year/Year Chg | (25.6%) | (40.5%) | (95.0%) | |
| Financials | PROF | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $19 | $128 | 13% |
|
| Net Income (TTM) (Mil) | ($33) | ($9) | 20% |
|
| EPS (TTM) | ($0.981) | ($0.400) | 22% |
|
| Operating Cash Flow (TTM) (Mil) | ($36) | ($2) | 11% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $3 | $26 | 21% |
|
| Enterprise Value (Q1) (Mil) | $225 | $409 | 27% |
|
| Valuation | PROF | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.87 | 2.49 | 79% |
|
| P/E | na | 25.3 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | PROF | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 71.8% | 59.0% | 82% |
|
| Net Margin | (171.6%) | (6.9%) | 5% |
|
| ROA | (58.4%) | (12.2%) | 10% |
|
| ROE | (73.5%) | (10.7%) | 12% |
|
| Liabilities to Assets | 20.2% | 47.2% | 13% |
|
| F-Score | 4 | 4 | 33% |
|
Profound Medical Corp. did not pass any screens on 10/14/2026.
